- Home
- ARDX vs BBN Comparison
ARDX vs BBN Comparison
Compare ARDX & BBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- BBN
- Stock Information
- Founded
- ARDX 2007
- BBN 1983
- Country
- ARDX United States
- BBN United States
- Employees
- ARDX N/A
- BBN N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- BBN Finance Companies
- Sector
- ARDX Health Care
- BBN Finance
- Exchange
- ARDX Nasdaq
- BBN Nasdaq
- Market Cap
- ARDX 882.9M
- BBN 968.9M
- IPO Year
- ARDX 2014
- BBN N/A
- Fundamental
- Price
- ARDX $4.32
- BBN $16.07
- Analyst Decision
- ARDX Strong Buy
- BBN
- Analyst Count
- ARDX 9
- BBN 0
- Target Price
- ARDX $10.17
- BBN N/A
- AVG Volume (30 Days)
- ARDX 4.6M
- BBN 231.8K
- Earning Date
- ARDX 07-31-2025
- BBN 01-01-0001
- Dividend Yield
- ARDX N/A
- BBN 6.90%
- EPS Growth
- ARDX N/A
- BBN N/A
- EPS
- ARDX N/A
- BBN N/A
- Revenue
- ARDX $361,706,000.00
- BBN N/A
- Revenue This Year
- ARDX $12.01
- BBN N/A
- Revenue Next Year
- ARDX $34.66
- BBN N/A
- P/E Ratio
- ARDX N/A
- BBN N/A
- Revenue Growth
- ARDX 127.33
- BBN N/A
- 52 Week Low
- ARDX $3.21
- BBN $14.33
- 52 Week High
- ARDX $7.18
- BBN $18.36
- Technical
- Relative Strength Index (RSI)
- ARDX 63.34
- BBN 59.19
- Support Level
- ARDX $3.49
- BBN $15.90
- Resistance Level
- ARDX $4.34
- BBN $16.20
- Average True Range (ATR)
- ARDX 0.17
- BBN 0.15
- MACD
- ARDX 0.08
- BBN 0.04
- Stochastic Oscillator
- ARDX 82.35
- BBN 79.03
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
About BBN BlackRock Taxable Municipal Bond Trust of Beneficial Interest
BlackRock Taxable Municipal Bond Trust is a diversified, closed-end management investment company. Its investment objective is to seek high current income, with a secondary objective of capital appreciation.